Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 1;37(9):474-477.
doi: 10.1097/PEC.0000000000002526.

Methylene Blue: An Antidote for Methemoglobinemia and Beyond

Renita S Pushparajah Mak  1 , Erica L Liebelt
Affiliations
Review

Methylene Blue: An Antidote for Methemoglobinemia and Beyond

Renita S Pushparajah Mak et al. Pediatr Emerg Care. .

Abstract

Methylene blue has been in medicinal use for centuries and is best known as an antidotal treatment for acquired methemoglobinemia (MetHB). More recently, methylene blue has gained recognition for its efficacious use in the treatment of ifosfamide neurotoxicity and refractory vasoplegic shock in both the pediatric and adult critical care literature, extending its use beyond MetHB. Methylene blue's mechanism of action is somewhat complex and based partly on its oxidizing capabilities, ironically the same mechanism that causes MetHB. This review will examine methylene blue's use in the treatment of acquired MetHB and ifosfamide neurotoxicity and review the current literature regarding its role in critically ill pediatric and adult patients with refractory vasoplegic shock. Methylene blue's pharmacologic actions, dosing, and adverse effects will also be discussed.

PubMed Disclaimer

References

    1. Saha BK, Burns SL. The story of nitric oxide, sepsis and methylene blue: a comprehensive pathophysiologic review. Am J Med Sci . 2020;360:329–337.
    1. Hosseinian L, Weiner M, Levin MA, et al. Methylene blue: magic bullet for vasoplegia? Anesth Analg . 2016;122:194–201.
    1. McCartney SL, Duce L, Ghadimi K. Intraoperative vasoplegia: methylene blue to the rescue. Curr Opin Anaesthesiol . 2018;31:43–49.
    1. Rutledge C, Brown B, Benner K, et al. A novel use of methylene blue in the pediatric ICU. Pediatrics . 2015;136:e1030–e1034.
    1. Howland MA. Antidotes in depth: methylene blue. In: Flomenbaum N, ed. Goldfrank's Toxicologic Emergencies . 11th ed. New York: McGraw-Hill; 2006:1713–1717.

LinkOut - more resources